GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (FRA:SYK) » Definitions » Cyclically Adjusted FCF per Share

Stryker (FRA:SYK) Cyclically Adjusted FCF per Share : €5.31 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Stryker Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Stryker's adjusted free cash flow per share for the three months ended in Mar. 2024 was €0.088. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €5.31 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Stryker's average Cyclically Adjusted FCF Growth Rate was 5.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 9.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 7.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Stryker was 81.70% per year. The lowest was 3.90% per year. And the median was 13.80% per year.

As of today (2024-05-04), Stryker's current stock price is €305.00. Stryker's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €5.31. Stryker's Cyclically Adjusted Price-to-FCF of today is 57.44.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Stryker was 62.24. The lowest was 24.89. And the median was 44.84.


Stryker Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Stryker's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Cyclically Adjusted FCF per Share Chart

Stryker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.51 3.45 4.43 5.00 5.19

Stryker Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.96 5.07 5.35 5.19 5.31

Competitive Comparison of Stryker's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Stryker's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stryker's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Stryker's Cyclically Adjusted Price-to-FCF falls into.



Stryker Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Stryker's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.088/129.4194*129.4194
=0.088

Current CPI (Mar. 2024) = 129.4194.

Stryker Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.600 100.560 0.772
201409 0.988 100.428 1.273
201412 1.308 99.070 1.709
201503 0.805 99.621 1.046
201506 0.676 100.684 0.869
201509 -1.371 100.392 -1.767
201512 1.636 99.792 2.122
201603 0.350 100.470 0.451
201606 0.891 101.688 1.134
201609 0.903 101.861 1.147
201612 1.288 101.863 1.636
201703 0.030 102.862 0.038
201706 1.216 103.349 1.523
201709 -0.139 104.136 -0.173
201712 1.093 104.011 1.360
201803 0.375 105.290 0.461
201806 1.108 106.317 1.349
201809 1.077 106.507 1.309
201812 2.063 105.998 2.519
201903 0.446 107.251 0.538
201906 0.814 108.070 0.975
201909 1.113 108.329 1.330
201912 1.269 108.420 1.515
202003 1.065 108.902 1.266
202006 1.208 108.767 1.437
202009 1.697 109.815 2.000
202012 2.312 109.897 2.723
202103 0.812 111.754 0.940
202106 1.676 114.631 1.892
202109 1.784 115.734 1.995
202112 1.838 117.630 2.022
202203 0.199 121.301 0.212
202206 0.955 125.017 0.989
202209 1.987 125.227 2.054
202212 2.013 125.222 2.080
202303 0.768 127.348 0.780
202306 1.289 128.729 1.296
202309 2.201 129.860 2.194
202312 3.305 129.419 3.305
202403 0.088 129.419 0.088

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Stryker  (FRA:SYK) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Stryker's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=305.00/5.31
=57.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Stryker was 62.24. The lowest was 24.89. And the median was 44.84.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Stryker Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Stryker's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Stryker (FRA:SYK) Business Description

Address
2825 Airview Boulevard, Kalamazoo, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Stryker (FRA:SYK) Headlines

From GuruFocus

Q3 2023 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Stryker Corp To Host Investor Day Transcript

By GuruFocus Research 01-23-2024

Q3 2021 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2020 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024